- Home
- GOSS vs NIU Comparison
GOSS vs NIU Comparison
Compare GOSS & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- NIU
- Stock Information
- Founded
- GOSS 2015
- NIU 2014
- Country
- GOSS United States
- NIU China
- Employees
- GOSS N/A
- NIU N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- NIU Auto Manufacturing
- Sector
- GOSS Health Care
- NIU Consumer Discretionary
- Exchange
- GOSS Nasdaq
- NIU Nasdaq
- Market Cap
- GOSS 212.8M
- NIU 182.4M
- IPO Year
- GOSS 2019
- NIU 2018
- Fundamental
- Price
- GOSS $1.27
- NIU $4.15
- Analyst Decision
- GOSS Strong Buy
- NIU
- Analyst Count
- GOSS 5
- NIU 0
- Target Price
- GOSS $9.20
- NIU N/A
- AVG Volume (30 Days)
- GOSS 1.5M
- NIU 1.7M
- Earning Date
- GOSS 03-13-2025
- NIU 03-17-2025
- Dividend Yield
- GOSS N/A
- NIU N/A
- EPS Growth
- GOSS N/A
- NIU N/A
- EPS
- GOSS N/A
- NIU N/A
- Revenue
- GOSS $114,701,000.00
- NIU $450,507,095.00
- Revenue This Year
- GOSS N/A
- NIU $16.99
- Revenue Next Year
- GOSS $154.71
- NIU $9.18
- P/E Ratio
- GOSS N/A
- NIU N/A
- Revenue Growth
- GOSS N/A
- NIU 24.00
- 52 Week Low
- GOSS $0.50
- NIU $1.61
- 52 Week High
- GOSS $1.55
- NIU $4.25
- Technical
- Relative Strength Index (RSI)
- GOSS 51.40
- NIU 76.98
- Support Level
- GOSS $1.27
- NIU $3.56
- Resistance Level
- GOSS $1.48
- NIU $4.25
- Average True Range (ATR)
- GOSS 0.11
- NIU 0.32
- MACD
- GOSS -0.01
- NIU 0.14
- Stochastic Oscillator
- GOSS 51.90
- NIU 94.22
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, moped and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.